183
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G polymorphism and metabolic/proinflammatory factors in polycystic ovary syndrome

, , , , , , , & show all
Pages 936-939 | Received 23 Apr 2013, Accepted 20 Jun 2013, Published online: 30 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xiaocui Song, Li Ge, Dongsha Wang, Li Li, Dongmei Ma, Xiu Li & Xiaocui Song. (2022) Family-based analysis of -675 4G/5G polymorphism in the PAI-1 gene of polycystic ovary syndrome in Chinese population. Journal of Obstetrics and Gynaecology 42:7, pages 3304-3308.
Read now

Articles from other publishers (12)

Gun Ho Choi, Sung Hwan Cho, Hui Jeong An, Han Sung Park, Jeong Yong Lee, Eun Ju Ko, Seung Hun Oh, Ok Joon Kim & Nam Keun Kim. (2023) Association between PAI-1 Polymorphisms and Ischemic Stroke in a South Korean Case-Control Cohort. International Journal of Molecular Sciences 24:9, pages 8041.
Crossref
Giselle Adriana Abruzzese, Mariela Edith Velazquez, Gloria Edith Cerrone & Alicia Beatriz Motta. (2023) Polycystic ovary syndrome in Latin American populations: What is known and what remains unresolved. The Journal of Steroid Biochemistry and Molecular Biology 225, pages 106195.
Crossref
Jiaqi Zhai, Zijian Li, Yue Zhou & Xiuhua Yang. (2022) The role of plasminogen activator inhibitor-1 in gynecological and obstetrical diseases: An update review. Journal of Reproductive Immunology 150, pages 103490.
Crossref
Seher Polat & Yasin Şimşek. (2021) Plasminogenactivator inhibitor-1 polymorphism and risk of polycystic ovary syndrome in Turkish women. Meta Gene 30, pages 100959.
Crossref
I. S. Silva, C. N. Ferreira, L. B. X. Costa, M. O. Sóter, L. M. L. Carvalho, J. de C. Albuquerque, M. F. Sales, A. L. Candido, F. M. Reis, A. A. Veloso & K. B. Gomes. (2021) Polycystic ovary syndrome: clinical and laboratory variables related to new phenotypes using machine-learning models. Journal of Endocrinological Investigation 45:3, pages 497-505.
Crossref
Michele d’Angelo, Vanessa Castelli, Maria Grazia Tupone, Mariano Catanesi, Andrea Antonosante, Reyes Dominguez-Benot, Rodolfo Ippoliti, Anna Maria Cimini & Elisabetta Benedetti. (2019) Lifestyle and Food Habits Impact on Chronic Diseases: Roles of PPARs. International Journal of Molecular Sciences 20:21, pages 5422.
Crossref
P. V. PopovaI. V. GorelovaE. N. Grineva. (2019) Polycystic ovary syndrome and cardiovascular risk. "Arterial’naya Gipertenziya" ("Arterial Hypertension") 24:6, pages 654-665.
Crossref
Laura M. L. Carvalho, Fernando M. dos Reis, Ana Lucia Candido, Fernanda F. C. Nunes, Claudia N. Ferreira & Karina B. Gomes. (2018) Polycystic Ovary Syndrome as a systemic disease with multiple molecular pathways: a narrative review. Endocrine Regulations 52:4, pages 208-221.
Crossref
Katica Bajuk Studen & Marija Pfeifer. (2018) Cardiometabolic risk in polycystic ovary syndrome. Endocrine Connections 7:7, pages R238-R251.
Crossref
Yao Ye, Aurelia Vattai, Xi Zhang, Junyan Zhu, Christian Thaler, Sven Mahner, Udo Jeschke & Viktoria Von Schönfeldt. (2017) Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases. International Journal of Molecular Sciences 18:8, pages 1651.
Crossref
Mirelle O. Sóter, Cláudia N. Ferreira, Mariana F. Sales, Ana L. Candido, Fernando M. Reis, Kátia S. Milagres, Carla Ronda, Ieda O. Silva, Marinez O. Sousa & Karina B. Gomes. (2015) Peripheral blood-derived cytokine gene polymorphisms and metabolic profile in women with polycystic ovary syndrome. Cytokine 76:2, pages 227-235.
Crossref
Ying Liu, Mei-Guo Sun, Rong Jiang, Rui Ding, Zhen Che, Yan-Yan Chen, Ci-Jiang Yao, Xiao-Xia Zhu & Ji-Yu Cao. (2014) Plasminogen Activator Inhibitor-1 -675 4G/5G Polymorphism and Polycystic Ovary Syndrome Risk: A Meta Analysis. Journal of Assisted Reproduction and Genetics 31:3, pages 363-370.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.